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Abstract: Long-term survival after hamster-to-rat liver xenotransplantation 
has provided the opportunity to study the posttransplantation source of 
major serum proteins and the functional consequences of several different 
receptor-ligand interactions, where one or the other is a xenogeneic protein. 
We report here that serum albumin, a-I-antitrypsin, complement 
component 3, and other acute phase reactants switch from recipient to 
donor origin during the first week after transplantation while serum 
immunoglobulins remain largely that of recipient. Despite the disparate 
source of complement (hamster) and immunoglobulins (rat), these two 
proteins were able to cooperate effectively to produce lysis of sheep red 
blood cells. Moreover, rat IgA was successfully processed by hamster 
hepatocytes and biliary epithelial cells, being present in the bile of 
successful liver xenograft recipients within one day after transplantation. 
The ability of these liver xenograft recipients to survive long-term in 
conventional and viral-free animal facilities without grossly obvious 
morbidity or unusual susceptibility to stress, suggests that xenogeneic 
proteins are able to successfully interact with several different physiologic 
systems in the hamster-to-rat combination. 
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Introduction 
Features such as resistance to humoral or antibody-
mediated rejection and a "tolerogenic" influence on 
the recipient's immune system make the liver an 
attractive organ to use in breaking the immunologic 
barrier of animal-to-human xenotransplantation 
[1,2]. However, given the liver's key role in main-
taining the biochemical homeostasis within the 
body, hepatic xenografts may also provide some of 
the most formidable challenges. Complex metabolic 
and immunologic functions require the liver, or its 
genetically encoded products [3], to integrate with 
a number of physiological systems in the body, 
where nonfunctionality, incompatibility, or even im-
munogenicity of xenogeneic proteins may pose ma-
jor problems. For example, serum proteins are 
synthesized largely by hepatocytes and then released 
into the circulation where they interact with many 
other cells throughout the body. Other proteins are 
produced by and remain in the hepatocytes, where 
they serve as receptors for hormones, growth fac-
tors, and immunoglobulins, the ligands for which 
are recipient proteins. 
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The achievement of long-term survival in the 
hamster-to-rat hepatic xenograft model using com-
bination immunosuppressive therapy has made fea-
sible the study of the physiological effects of 
xenogeneic serum albumin and coagulation factors 
[4]. Both of these important physiologic proteins 
switch to donor origin within a few days after trans-
plantation and remain so for the life of the graft/re-
cipient [4]. The present study was undertaken to 
determine a) if as expected the liver was the ma-
jor source of complement component 3 (C3) af-
ter hepatic xenotransplantation; b) if the hamster 
C3 produced by the liver could interact with rat im-
munoglobulin G to produce cell lysis; and c) if ham-
ster secretory component produced by hepatocytes 
and biliary epithelium, could successfully transport 
rat IgA from the serum into the bile. 
Materials and methods 
Animals, operative procedures, and immunosuppression 
Male Syrian Golden Hamsters (100-120 g) and 
male LEWIS rats (250-270 g) were purchased from 
Charles River Laboratories (Wilmington, MA) and 
used as liver donors and recipients, respectively. 
Orthotopic liver transplantation was according to the 
cuff technique [5] with modifications which in-
cluded donor cholecystectomy r6]. After liver trans-
plantation, the rats were maintained under standard 
clean conditions, having free access to rodent chow 
and water and given 1 mg/kg/day of intramuscular 
FK-506 (Fujisawa Pharmaceuticals, Japan) for one 
month, and 8 mg/kg/day of intraperitoneal Cyclo-
phosphamide (Sigma Chemical Co., St. Louis, MO) 
for 6 days. All therapy was then stopped. This treat-
ment results in 80% recipient survival for more than 
100 days. 
To ensure collection of plasma without comple-
ment breakdown for subsequent testing (see below), 
the abdominal portion of the aorta and inferior vena 
cava were mobilized, clamped at the level of the re-
nal vessels and severed at their bifurcation. After 
inserting both free ends of the vessels into a test tube 
containing EDT A (Vacutainer 6384-Becton Dick-
inson, Rutherford, NJ) the clamp was removed and 
the sample collected. 
Double and radial immunodiffusion assays 
Double immunodiffusion was done using 1.D. discs 
with indicators (Cappel-Organon Teknika, West 
Chester, PA). Briefly, 17.5 III of serum from nor-
mal rat, hamster, and liver xenograft recipients ob-
tained at 5, 36, 72, and 137 days after transplantation 
were tested against goat anti-rat IgG antibodies 
(Sigma). After 48 h of diffusion, the lines of pre-
cipitation between the anti-IgG sera in the central 
well and the test sera listed above were evaluated. 
Similar tests were carried out using mouse anti-ham-
ster IgG and IgM monoclonal antibodies (Sigma). 
The Mancini technique was used for radial im-
munodiffusion [7], Twenty microliters of bile from 
a normal rat and hamster or from a liver xenograft 
recipient 1, 3, and 5 days after transplantation were 
placed in wells in an agarose gel radial immuno-
diffusion plate (RID) containing monospecific goat 
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anti-rat IgA antibody (The Binding Site, Inc., San 
Diego, CA). The ring of precipitation formed after 
diffusion for 24 h at room temperature in different 
wells was compared to the ring of precipitation pro-
duced by a known amount of rat IgA. 
Electrophoresis and immunofixation 
Plasma proteins were electrophoresed for 30 min at 
250 volts in 1% agarose gel (SEAKEM-ME, FMC, 
Rockland, ME) containing 75 mm Veronal buffer, 
and subsequently stained with a mixture of Amido 
black and Coomassie brilliant blue (Sigma) (80:20 
vol/vol). In order to detect the location of the C3 
migration band, electrophoresis was performed in 
two gels with the same three plasma samples (from 
normal rat, hamster, and liver xenograft recipient) 
running simultaneously under similar conditions. 
One gel was then immediately stained for standard 
detection of the migration bands, while the other gel 
was incubated with goat anti-rat C3 monoclonal an-
tibody (mAb) (Cappel) for 1 hr at room tempera-
ture in a humidified chamber and then stained with 
Amido black/Coomassie blue. 
Hemolytic assay 
The ability of complement contained in sheep red 
blood cell (SRBC) absorbed semm obtained from 1) 
a liver xenograft recipient (hamster-to-rat) 36 days af-
ter transplantation; 2) a normal rat or 3) a normal ham-
ster, to lyse SRBC in the presence of a known amount 
of rat antibodies was tested using a modified Mayer's 
method [8]. The test sera were prepared by absorption 
with fixed SRBC for 15 min at 4°C. The rat anti-se-
rum was prepared by injection (x2) of SRBC into the 
peritoneal cavity of LEWIS rats at 2 week intervals. 
One week after the last injection, the animals were sac-
rificed and the anti-serum obtained was then diluted 
to 1: 16 with PBS containing 0.01 M EDTA. The anti-
body solution was added with an equal volume of 
SRBC (5x106/ml) resuspended in PBS and 1 % gela-
tin (PBSG), incubated at 37°C for 30 min and washed 
(x3) with PBSG containing 0.15 mM Ca++ and 0.5 mM 
Mg++ (PBSG2+). One hundred microliters of the sensi-
tized SRBC were then placed into each well of a 96-
well U-bottomed microliter plate (Becton Dickinson, 
Lincoln Park, NJ) and as a source of complement, dif-
ferent volumes of absorbed sera (1:2 dilution), were 
added. Additional PBSG2+ was added to each well to 
bring the volume up to 200 Ill/well, the plates were 
incubated for 9 h at 37°C, and then centrifuged for 2 
min at 300g. The plates were read by measuring the 
absorbance of the supernatant at 405 nm using a 
VMAX Spectrophotometer (Molecular Devices, 
Menlo Park, CA). Wells that contained complement 
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plus antibodies but no SRBC's were included as 
background controls. Additional controls included 
wells containing only SRBC or SRBC and comple-
ment without antibodies to exclude the contribution, 
if any, of spontaneous hemolysis of the SRBC as 
well as activation of complement through the alter-
native pathway. 
Immunohistochemical studies 
Liver tissues from a normal rat, hamster, and a rat 
liver xenograft recipient 30 days after transplanta-
tion were snap-frozen in OCT compound (Tissue-
tek, Ames Division, Miles Laboratories, Inc., 
Elkhart, IN) and sectioned at 6 microns. Immuno-
globulins within the liver tissue were localized with 
a standard avidin-biotin-complex technique using a 
monoclonal mouse anti-rat IgA (2360-MCA 191-
Serotec-Accurate, Westbury, NY) as the primary 
immunoreactant. 
Results 
Origin of plasma proteins, including immunoglobulins and 
complement component 3 
The electrophoresis profile of plasma proteins ob-
tained from normal rat, hamster, and a liver xe-
nograft recipient, 17 days after transplantation, are 
shown in Figure 1. Migration of albumin and a-l-
antitrypsin from the liver xenograft recipient were 
rat 
OlT 
17d. 
ham 
.. ALB . 
.. ({-1 -AT 
.. C3 
Fig . I. Gel electrophoresis of plasma proteins shows that the 
profile of a liver xenograft recipient is more similar to the do-
nor (hamster) than that to the recipient (rat). Immunofixation 
with goat anti-rat C3 mAb shows that the upper band in the 
~O-globulin region is C3 and is derived from the donor (ham-
ster) and not the recipient (rat). 
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almost identical to that from a normal hamster, in-
dicating that major plasma proteins in the recipient 
have been replaced by those from the donor. Fur-
thermore, there were two bands of identical migration 
patterns, which were localized to the ~O-globulin re-
gion of the xenograft recipient and normal hamster 
(Fig. 1). Immunofixation studies using goat anti-rat 
C3 mAb (which crossreacts with both hamster and 
rat), highlighted only the upper band in the ~O-
globulin region both in the plasma from normal 
hamster and liver xenograft (hamster-to-rat) recipi-
ent, suggesting that the plasma C3 in the recipient 
is of donor origin. In contrast, this doublet was less 
distinct and C3 migration was somewhat retarded 
in the plasma of normal rat as compared to the same 
in normal hamster and liver xenograft recipient. 
These studies suggest that the plasma C3 detectable 
by electrophoresis and immunofixation in a liver 
xenograft recipient posttransplantation was of do-
nor (hamster) origin. 
In contrast to other major proteins, the bulk of 
the serum immunoglobulins in liver xenograft re-
cipients remained that of the host (rat) (Fig. 2). 
This was confirmed by similar double immunod-
iffusion analysis using mouse anti-hamster IgG 
ham 
serum 
OLT \ ~ rat 
137d. serum 
(" " , I ~~ OlT OLT 
72d. \ Sd. 
(, ~ 
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( "\ 
, 
~ 
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Fig. 2. Double immunodiffusion shows that the circulating 
immunoglobulins remain of reCipient origin after hepatic xe-
notransplantation. The central well contains goat anti-rat IgG, 
which forms a line or precipitation with the serum from liver 
xenograft recipients at 5, 36, 72, and 137 days after transplan-
tation. Note the absence of a precipitation line with the nor-
mal hamster serum. 
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FiR. 3. Hemolytic assay. As a source of complement activ-
ity, serum from liver xenograft recipients 37 days after trans-
plantation ("") was as efficient as normal rat serum (0) but 
more effective than normal hamster serum (e) in producing 
lysis of sensitized SRBC (see methods). There was no signifi-
cant statistical difference in the activity of complement of nor-
mal and transplanted rats. 
and IgM antibodies, which showed lack of pre-
cipitation line with the serum of liver xenograft 
recipients at several times after transplantation 
(data not shown). 
Cooperation of rat immunoglobulins and hamster 
complement in a hemolytic assay 
Since the circulating immunoglobulins in liver xe-
nograft recipients are largely derived from the re-
cipient (rat), whereas most of the complement 
components are of donor (hamster) origin, we tested 
whether serum, as a source of complement, from a 
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liver xenograft recipient could lyse SRBC sensitized 
with rat immunoglobulins. The results shown in Fig-
ure 3 were compared to SRBC lysis produced by 
normal rat and hamster serum in the same assay. 
Serum from a liver xenograft recipient 36 days af-
ter transplantation mediated lysis of SRBC sensi-
tized with rat immunoglobulin as efficiently as that 
produced by serum from a normal rat and more ef-
fectively than normal hamster serum. 
Processing and biliary secretion of rat IgA by a successful 
hamster liver xenograft 
The liver normally processes serum IgA by selec-
tive absorption, conjugation with the secretory com-
ponent, transcellular processing, and finally, 
secretion into the bile. We determined the origin and 
if present, the concentration of rat IgA in the bile 
from liver xenografts 1, 3, and 5 days after trans-
plantation. The results in Figure 4 show that within 
I day after transplantation, a small amount of rat 
IgA can be detected in the bile of a hamster-to-rat 
liver xenograft. The concentration of rat IgA reaches 
near normal levels by day 5 and can be immuno-
histochemically detected in the expected areas of 
deposition (canaliculi and bile ducts) by day 30 af-
ter transplantation (Fig. 5). 
Discussion 
These results confirm and extend our previous ob-
servations that liver xenografts retain the metabolic 
specificity of the donor after placement into a new 
host [4] in the same way as was originally shown 
for allografts almost 30 years ago [9,10]. This fact 
Fig 4. Radial immunodiffusion 
shows the presence of rat IgA in the 
bile of liver xenograft recipients. In 
this test, the agar plate contained 
goat anti-rat IgA. The wells (from 
left -7 right) were filled with normal 
hamster bile, 72 mg/L of rat IgA, 
(positive control), bile from hepatic 
liver xenograft recipients day 1, 3 
and 5 after transplantation and nor-
mal rat bile. 
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FiR . 5 . Rat IgA (arrows) could be seen in the normal areas 
of deposition (biliary canaliculi) in this normally functioning 
hamster-to-rat liver xenograft, 30 days after transplantation . 
has been used as a rationale for the treatment of 
many hepatic-based metabolic diseases with a liver 
transplant, which conversely, can also transfer a 
metabolic disorder from the donor to the recipient. 
Because receptor-ligand pairs derived from two 
separate species could result in molecular deficits 
or incompatibilities, the potential metabolic risks of 
hepatic xenotransplantation must be carefully stud-
ied. These observations prompted us to undertake 
more detailed examination of ostensibly healthy rats 
bearing hamster livers, beyond that previously re-
ported [4] . 
The structures of albumin and a-I-antitrypsin 
secreted in the xenogeneic liver recipient (rat) 
were genetically encoded in the donor (hamster) 
hepatocytes genome. Their expression, however, 
was influenced by recipient's extrahepatic factors 
such as thyroid and growth hormones, glucocor-
ticoids and insulin [11]. Similarly, donor C3 and 
other xenogeneic acute phase reactants also ap-
peared to respond to recipient cytokines, such as 
IL-6 in that there was no obv ious ev idence of a 
breakdown of these interactions. 
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The inset (original magnification 400x) shows the staining de-
tail of rat IgA (large arrow). No staining was detected in a con-
trol animal hamster liver (not shown) . 
Conversely, the bulk of the serum immunoglobu-
lins in these animals remained of rat origin. How-
ever, despite a complete switch-over of important 
serum oncotic proteins and acute phase reactants to 
that of a donor with retention of recipient's immu-
noglobulins, no edema, wasting syndrome, or un-
usual susceptibility to stress or infection was 
observed during postoperative follow-up of the liver 
xenograft recipients [12]. These gross observations 
suggested that the hamster xenoproteins were prop-
erly functioning in the rat recipients maintained in 
either open or viral-free animal facilities. 
A more specific example of functional coopera-
tion between hamster and rat xenoproteins was pro-
vided herein by the in vitro lysis of sensitized 
SRBCs using rat immunoglobulin and SRBC ab-
sorbed liver xenograft recipient's serum as a source 
of complement. Alper et aI., [13] have previously 
demonstrated that the liver is the major site of C3 
biosynthesis with an electrophoretic shift of the 
same from the recipient FS type to the donor SS 
type after hepatic allotransplantation in man [14]. 
However, there is contrasting evidence that suggests 
the existence of extrahepatic sites of complement 
synthesis [15]. Although, by definition, a mixed mi-
lieu of complement is present, the sensitivity of elec-
trophoresis and immunofixation techniques used in 
our studies was probably not high enough to detect 
any C3 in the circulation except that of hamster (do-
nor) origin. The trace quantities of rat complement 
from extrahepatic sources could therefore account 
for the slightly more efficient lysis of SRBC by the 
hamsterized recipient serum than by normal ham-
ster serum. It should also be noted that nonhepatic 
complement may be more important in local inflam-
matory responses, such as those involved in autoim-
mune processes [16]. 
The presence of rat IgA in the bile after hepatic 
xenotransplantation mirrored another example of 
successful collaboration between xenogeneic pro-
teins, in this case involving a recipient immunoglo-
bulin whose uptake, processing, and conjugation is 
dependent on a xenogeneic secretory component 
[17]. Although no evidence of metabolic incompat-
ibilities between xenogeneic proteins has been un-
covered to date, there may be subtle changes, 
particularly with disparate species that could ruin the 
long-term results of human liver xenotransplanta-
tion. The extent of this problem, if it at all exists, 
and its implications can be more comprehensively 
analyzed by evolving better strategies that will miti-
gate the consequences of complement activation 
syndrome, one that has frustrated the practical ap-
plication of xenotransplantation for decades [18]. 
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